[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f-9g9n672RmVGsWuSB9v9ggx9zSY12pJaGs9itIsypUc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":69,"rows":76},"Beijing Chao Yang Hospital",[4],126,false,32,3,43747,9,78,[14,17,19,22,25,27,29,31],{"name":15,"count":16},"Pulmonary Embolism",6,{"name":18,"count":16},"Type 2 Diabetes",{"name":20,"count":21},"Acute Respiratory Distress Syndrome",5,{"name":23,"count":24},"Rectal Cancer",4,{"name":26,"count":9},"Thromboembolism",{"name":28,"count":9},"Acute Exacerbation of Chronic Obstructive Pulmonary Disease",{"name":30,"count":9},"Obesity",{"name":32,"count":9},"Postoperative Delirium",[34,39,44,49,54,59,64],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05202314","Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer","2023-12-30","Immunotherapy",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT07323134","The Effect of Semaglutide on the Intestinal Flora in Obesity","2026-08-01","Semaglutide",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT04916197","Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET)","2026-12","Dexmedetomidine prolonged sedation",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06825793","Semaglutide's Weight Loss Effects in Obesity","2026-12-31","Semaglutide Subcutaneous",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT06919575","A Individualized Physical Function Improvement Program for Frailty Elderly Using Goal Attainment Scaling (GAS) as Evaluation Method: Protocol for a Randomized Controlled Trial","2027-01-01","Multicomponent frailty intervention",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT07563673","Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction（ELASTIC）","2027-09-30","Aspirin",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT06676085","A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation","2027-12-31","Nafamostat",[70,71,72,73,74,75],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[77,102,125,143,165,183,203,228,248,270,310,332,368,393,418,440,466,491,509,535,560,578,603,630,648,674,698,723,741,764,782,809,827,852,893,930,958,986,1009,1027,1051,1069,1095,1119,1143,1168,1186,1211,1229,1247,1273,1297,1320,1345,1371,1396,1421,1439],{"intervention":63,"totalTrials":78,"cells":79},1,{"EARLY_PHASE1":80,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":89,"NA":100},{"trials":81,"activeCount":82},[],0,{"trials":84,"activeCount":82},[],{"trials":86,"activeCount":82},[],{"trials":88,"activeCount":82},[],{"trials":90,"activeCount":78,"soonestReadout":62},[91],{"nctId":60,"briefTitle":61,"status":92,"phases":93,"primaryCompletion":62,"completion":67,"start":94,"enrollment":95,"conditions":96,"interventions":99},"NOT_YET_RECRUITING",[74],"2026-05-01",210,[97,98],"Cerebral Infarction","Thrombolysis",[63,63],{"trials":101,"activeCount":82},[],{"intervention":48,"totalTrials":78,"cells":103},{"EARLY_PHASE1":104,"PHASE1":106,"PHASE2":108,"PHASE3":110,"PHASE4":112,"NA":123},{"trials":105,"activeCount":82},[],{"trials":107,"activeCount":82},[],{"trials":109,"activeCount":82},[],{"trials":111,"activeCount":82},[],{"trials":113,"activeCount":78,"soonestReadout":47},[114],{"nctId":45,"briefTitle":46,"status":115,"phases":116,"primaryCompletion":47,"completion":47,"start":117,"enrollment":118,"conditions":119,"interventions":121},"RECRUITING",[74],"2024-03-01",368,[120],"Acute Ischemic Stroke",[48,122],"0.9% saline",{"trials":124,"activeCount":82},[],{"intervention":122,"totalTrials":78,"cells":126},{"EARLY_PHASE1":127,"PHASE1":129,"PHASE2":131,"PHASE3":133,"PHASE4":135,"NA":141},{"trials":128,"activeCount":82},[],{"trials":130,"activeCount":82},[],{"trials":132,"activeCount":82},[],{"trials":134,"activeCount":82},[],{"trials":136,"activeCount":78,"soonestReadout":47},[137],{"nctId":45,"briefTitle":46,"status":115,"phases":138,"primaryCompletion":47,"completion":47,"start":117,"enrollment":118,"conditions":139,"interventions":140},[74],[120],[48,122],{"trials":142,"activeCount":82},[],{"intervention":68,"totalTrials":78,"cells":144},{"EARLY_PHASE1":145,"PHASE1":147,"PHASE2":149,"PHASE3":151,"PHASE4":153,"NA":155},{"trials":146,"activeCount":82},[],{"trials":148,"activeCount":82},[],{"trials":150,"activeCount":82},[],{"trials":152,"activeCount":82},[],{"trials":154,"activeCount":82},[],{"trials":156,"activeCount":78,"soonestReadout":67},[157],{"nctId":65,"briefTitle":66,"status":115,"phases":158,"primaryCompletion":67,"completion":67,"start":159,"enrollment":160,"conditions":161,"interventions":163},[75],"2024-11-01",60,[162],"ECMO",[68,164],"Heparin",{"intervention":164,"totalTrials":78,"cells":166},{"EARLY_PHASE1":167,"PHASE1":169,"PHASE2":171,"PHASE3":173,"PHASE4":175,"NA":177},{"trials":168,"activeCount":82},[],{"trials":170,"activeCount":82},[],{"trials":172,"activeCount":82},[],{"trials":174,"activeCount":82},[],{"trials":176,"activeCount":82},[],{"trials":178,"activeCount":78,"soonestReadout":67},[179],{"nctId":65,"briefTitle":66,"status":115,"phases":180,"primaryCompletion":67,"completion":67,"start":159,"enrollment":160,"conditions":181,"interventions":182},[75],[162],[68,164],{"intervention":53,"totalTrials":78,"cells":184},{"EARLY_PHASE1":185,"PHASE1":187,"PHASE2":189,"PHASE3":191,"PHASE4":193,"NA":195},{"trials":186,"activeCount":82},[],{"trials":188,"activeCount":82},[],{"trials":190,"activeCount":82},[],{"trials":192,"activeCount":82},[],{"trials":194,"activeCount":82},[],{"trials":196,"activeCount":78,"soonestReadout":52},[197],{"nctId":50,"briefTitle":51,"status":92,"phases":198,"primaryCompletion":52,"completion":67,"start":199,"enrollment":200,"conditions":201,"interventions":202},[75],"2025-02-20",56,[30],[53],{"intervention":38,"totalTrials":78,"cells":204},{"EARLY_PHASE1":205,"PHASE1":207,"PHASE2":209,"PHASE3":211,"PHASE4":213,"NA":215},{"trials":206,"activeCount":82},[],{"trials":208,"activeCount":82},[],{"trials":210,"activeCount":82},[],{"trials":212,"activeCount":82},[],{"trials":214,"activeCount":82},[],{"trials":216,"activeCount":78,"soonestReadout":37},[217],{"nctId":35,"briefTitle":36,"status":115,"phases":218,"primaryCompletion":37,"completion":219,"start":220,"enrollment":221,"conditions":222,"interventions":227},[75],"2026-12-30","2021-12-12",20,[223,224,225,226,38],"Colorectal Cancer","Neoadjuvant Chemotherapy","Stent","Obstruction",[38],{"intervention":43,"totalTrials":78,"cells":229},{"EARLY_PHASE1":230,"PHASE1":232,"PHASE2":234,"PHASE3":236,"PHASE4":238,"NA":240},{"trials":231,"activeCount":82},[],{"trials":233,"activeCount":82},[],{"trials":235,"activeCount":82},[],{"trials":237,"activeCount":82},[],{"trials":239,"activeCount":82},[],{"trials":241,"activeCount":78,"soonestReadout":42},[242],{"nctId":40,"briefTitle":41,"status":92,"phases":243,"primaryCompletion":42,"completion":42,"start":244,"enrollment":245,"conditions":246,"interventions":247},[],"2026-02-01",40,[30],[43],{"intervention":58,"totalTrials":78,"cells":249},{"EARLY_PHASE1":250,"PHASE1":252,"PHASE2":254,"PHASE3":256,"PHASE4":258,"NA":260},{"trials":251,"activeCount":82},[],{"trials":253,"activeCount":82},[],{"trials":255,"activeCount":82},[],{"trials":257,"activeCount":82},[],{"trials":259,"activeCount":82},[],{"trials":261,"activeCount":78,"soonestReadout":57},[262],{"nctId":55,"briefTitle":56,"status":92,"phases":263,"primaryCompletion":57,"completion":264,"start":265,"enrollment":266,"conditions":267,"interventions":269},[75],"2027-08-01","2025-05-01",160,[268],"Elderly",[58],{"intervention":271,"totalTrials":272,"cells":273},"Tropisetron",2,{"EARLY_PHASE1":274,"PHASE1":276,"PHASE2":278,"PHASE3":280,"PHASE4":282,"NA":308},{"trials":275,"activeCount":82},[],{"trials":277,"activeCount":82},[],{"trials":279,"activeCount":82},[],{"trials":281,"activeCount":82},[],{"trials":283,"activeCount":82},[284,297],{"nctId":285,"briefTitle":286,"status":287,"phases":288,"primaryCompletion":289,"completion":290,"start":291,"enrollment":292,"conditions":293,"interventions":295},"NCT04027751","The Efficacy and Safety of Tropisetron in Preventing Emergence Delirium","UNKNOWN",[74],"2021-12-31","2022-03-31","2019-08-01",1508,[294,32],"Emergence Delirium",[271,296],"Placebos",{"nctId":298,"briefTitle":299,"status":287,"phases":300,"primaryCompletion":301,"completion":302,"start":303,"enrollment":304,"conditions":305,"interventions":307},"NCT04195204","A Pilot Trial Evaluating the Effect of Tropisetron on Postoperative Cognitive Dysfunction After Cardiac Surgery",[74],"2022-12-31","2023-06-30","2020-11-01",72,[306,32],"Postoperative Cognitive Dysfunction",[271,296],{"trials":309,"activeCount":82},[],{"intervention":296,"totalTrials":272,"cells":311},{"EARLY_PHASE1":312,"PHASE1":314,"PHASE2":316,"PHASE3":318,"PHASE4":320,"NA":330},{"trials":313,"activeCount":82},[],{"trials":315,"activeCount":82},[],{"trials":317,"activeCount":82},[],{"trials":319,"activeCount":82},[],{"trials":321,"activeCount":82},[322,326],{"nctId":285,"briefTitle":286,"status":287,"phases":323,"primaryCompletion":289,"completion":290,"start":291,"enrollment":292,"conditions":324,"interventions":325},[74],[294,32],[271,296],{"nctId":298,"briefTitle":299,"status":287,"phases":327,"primaryCompletion":301,"completion":302,"start":303,"enrollment":304,"conditions":328,"interventions":329},[74],[306,32],[271,296],{"trials":331,"activeCount":82},[],{"intervention":333,"totalTrials":272,"cells":334},"Urokinase",{"EARLY_PHASE1":335,"PHASE1":337,"PHASE2":339,"PHASE3":341,"PHASE4":343,"NA":366},{"trials":336,"activeCount":82},[],{"trials":338,"activeCount":82},[],{"trials":340,"activeCount":82},[],{"trials":342,"activeCount":82},[],{"trials":344,"activeCount":82},[345,355],{"nctId":346,"briefTitle":347,"status":348,"phases":349,"primaryCompletion":350,"completion":350,"start":351,"enrollment":352,"conditions":353,"interventions":354},"NCT00799968","12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China","COMPLETED",[74],"2006-02","2002-06",129,[15,26],[333,333],{"nctId":356,"briefTitle":357,"status":348,"phases":358,"primaryCompletion":359,"completion":359,"start":360,"enrollment":361,"conditions":362,"interventions":364},"NCT00968929","Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)",[74],"2009-05","2006-06",83,[15,363],"Pulmonary Thromboembolism",[365,333],"Recombinant Streptokinase",{"trials":367,"activeCount":82},[],{"intervention":369,"totalTrials":78,"cells":370},"fenofibrate",{"EARLY_PHASE1":371,"PHASE1":373,"PHASE2":375,"PHASE3":377,"PHASE4":379,"NA":391},{"trials":372,"activeCount":82},[],{"trials":374,"activeCount":82},[],{"trials":376,"activeCount":82},[],{"trials":378,"activeCount":82},[],{"trials":380,"activeCount":82},[381],{"nctId":382,"briefTitle":383,"status":287,"phases":384,"primaryCompletion":385,"completion":385,"start":386,"enrollment":387,"conditions":388,"interventions":390},"NCT02314533","Evaluate the Efficacy of Fenofibrate on Microalbuminuria",[74],"2016-12","2014-12",200,[389],"Microalbuminuria",[369],{"trials":392,"activeCount":82},[],{"intervention":394,"totalTrials":78,"cells":395},"Nadroparin",{"EARLY_PHASE1":396,"PHASE1":398,"PHASE2":400,"PHASE3":402,"PHASE4":404,"NA":416},{"trials":397,"activeCount":82},[],{"trials":399,"activeCount":82},[],{"trials":401,"activeCount":82},[],{"trials":403,"activeCount":82},[],{"trials":405,"activeCount":82},[406],{"nctId":407,"briefTitle":408,"status":348,"phases":409,"primaryCompletion":350,"completion":350,"start":351,"enrollment":410,"conditions":411,"interventions":414},"NCT00796692","Nadroparin for the Initial Treatment of Pulmonary Thromboembolism",[74],274,[15,26,412,413],"Vascular Diseases","Thrombosis",[394,415],"Unfractionated heparin",{"trials":417,"activeCount":82},[],{"intervention":419,"totalTrials":78,"cells":420},"rt-PA",{"EARLY_PHASE1":421,"PHASE1":423,"PHASE2":425,"PHASE3":427,"PHASE4":429,"NA":438},{"trials":422,"activeCount":82},[],{"trials":424,"activeCount":82},[],{"trials":426,"activeCount":82},[],{"trials":428,"activeCount":82},[],{"trials":430,"activeCount":82},[431],{"nctId":432,"briefTitle":433,"status":348,"phases":434,"primaryCompletion":350,"completion":350,"start":351,"enrollment":435,"conditions":436,"interventions":437},"NCT00781378","Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China",[74],118,[15,26],[419,419],{"trials":439,"activeCount":82},[],{"intervention":441,"totalTrials":78,"cells":442},"atorvastatin",{"EARLY_PHASE1":443,"PHASE1":445,"PHASE2":447,"PHASE3":449,"PHASE4":451,"NA":464},{"trials":444,"activeCount":82},[],{"trials":446,"activeCount":82},[],{"trials":448,"activeCount":82},[],{"trials":450,"activeCount":82},[],{"trials":452,"activeCount":82},[453],{"nctId":454,"briefTitle":455,"status":287,"phases":456,"primaryCompletion":457,"completion":458,"start":459,"enrollment":460,"conditions":461,"interventions":463},"NCT01033058","Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI",[74],"2011-03","2011-06","2009-12",500,[462],"STEMI",[441,441],{"trials":465,"activeCount":82},[],{"intervention":467,"totalTrials":78,"cells":468},"Sitagliptin",{"EARLY_PHASE1":469,"PHASE1":471,"PHASE2":473,"PHASE3":475,"PHASE4":477,"NA":489},{"trials":470,"activeCount":82},[],{"trials":472,"activeCount":82},[],{"trials":474,"activeCount":82},[],{"trials":476,"activeCount":82},[],{"trials":478,"activeCount":82},[479],{"nctId":480,"briefTitle":481,"status":287,"phases":482,"primaryCompletion":483,"completion":484,"start":485,"enrollment":221,"conditions":486,"interventions":487},"NCT05667220","Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes",[74],"2023-10-31","2023-12-31","2022-12-01",[18],[467,488],"Sitagliptin combined with Beidougen",{"trials":490,"activeCount":82},[],{"intervention":488,"totalTrials":78,"cells":492},{"EARLY_PHASE1":493,"PHASE1":495,"PHASE2":497,"PHASE3":499,"PHASE4":501,"NA":507},{"trials":494,"activeCount":82},[],{"trials":496,"activeCount":82},[],{"trials":498,"activeCount":82},[],{"trials":500,"activeCount":82},[],{"trials":502,"activeCount":82},[503],{"nctId":480,"briefTitle":481,"status":287,"phases":504,"primaryCompletion":483,"completion":484,"start":485,"enrollment":221,"conditions":505,"interventions":506},[74],[18],[467,488],{"trials":508,"activeCount":82},[],{"intervention":510,"totalTrials":78,"cells":511},"Levothyroxine Sodium",{"EARLY_PHASE1":512,"PHASE1":514,"PHASE2":516,"PHASE3":518,"PHASE4":520,"NA":533},{"trials":513,"activeCount":82},[],{"trials":515,"activeCount":82},[],{"trials":517,"activeCount":82},[],{"trials":519,"activeCount":82},[],{"trials":521,"activeCount":82},[522],{"nctId":523,"briefTitle":524,"status":287,"phases":525,"primaryCompletion":526,"completion":527,"start":528,"enrollment":529,"conditions":530,"interventions":532},"NCT04953195","Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism",[74],"2021-09-15","2021-10-30","2019-01-01",30,[531],"Subclinical Hypothyroidisms",[510],{"trials":534,"activeCount":82},[],{"intervention":536,"totalTrials":78,"cells":537},"Exenatide or metformin hydrochloride",{"EARLY_PHASE1":538,"PHASE1":540,"PHASE2":542,"PHASE3":544,"PHASE4":546,"NA":558},{"trials":539,"activeCount":82},[],{"trials":541,"activeCount":82},[],{"trials":543,"activeCount":82},[],{"trials":545,"activeCount":82},[],{"trials":547,"activeCount":82},[548],{"nctId":549,"briefTitle":550,"status":348,"phases":551,"primaryCompletion":552,"completion":552,"start":553,"enrollment":554,"conditions":555,"interventions":557},"NCT03297879","Comparison of Exenatide and Metformin Monotherapy in Overweight\u002FObese Patients With Newly Diagnosed Type 2 Diabetes",[74],"2016-02-28","2013-01-01",230,[556],"Type2 Diabetes",[536],{"trials":559,"activeCount":82},[],{"intervention":365,"totalTrials":78,"cells":561},{"EARLY_PHASE1":562,"PHASE1":564,"PHASE2":566,"PHASE3":568,"PHASE4":570,"NA":576},{"trials":563,"activeCount":82},[],{"trials":565,"activeCount":82},[],{"trials":567,"activeCount":82},[],{"trials":569,"activeCount":82},[],{"trials":571,"activeCount":82},[572],{"nctId":356,"briefTitle":357,"status":348,"phases":573,"primaryCompletion":359,"completion":359,"start":360,"enrollment":361,"conditions":574,"interventions":575},[74],[15,363],[365,333],{"trials":577,"activeCount":82},[],{"intervention":579,"totalTrials":78,"cells":580},"Sitagliptin 100mg",{"EARLY_PHASE1":581,"PHASE1":583,"PHASE2":585,"PHASE3":587,"PHASE4":589,"NA":601},{"trials":582,"activeCount":82},[],{"trials":584,"activeCount":82},[],{"trials":586,"activeCount":82},[],{"trials":588,"activeCount":82},[],{"trials":590,"activeCount":82},[591],{"nctId":592,"briefTitle":593,"status":287,"phases":594,"primaryCompletion":595,"completion":596,"start":597,"enrollment":598,"conditions":599,"interventions":600},"NCT04495881","Sitagliptin for the Treatment of Type 2 Diabetes",[74],"2025-06-01","2025-09-01","2020-01-01",50,[18],[579],{"trials":602,"activeCount":82},[],{"intervention":604,"totalTrials":78,"cells":605},"Recombinant tissue plasminogen activator",{"EARLY_PHASE1":606,"PHASE1":608,"PHASE2":610,"PHASE3":612,"PHASE4":614,"NA":628},{"trials":607,"activeCount":82},[],{"trials":609,"activeCount":82},[],{"trials":611,"activeCount":82},[],{"trials":613,"activeCount":82},[],{"trials":615,"activeCount":82},[616],{"nctId":617,"briefTitle":618,"status":287,"phases":619,"primaryCompletion":620,"completion":621,"start":622,"enrollment":623,"conditions":624,"interventions":626},"NCT01531829","Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD",[74],"2012-07","2012-12","2009-07",460,[625,15],"Pulmonary Thromboembolisms",[604,627],"Low Molecular Weight Heparin",{"trials":629,"activeCount":82},[],{"intervention":627,"totalTrials":78,"cells":631},{"EARLY_PHASE1":632,"PHASE1":634,"PHASE2":636,"PHASE3":638,"PHASE4":640,"NA":646},{"trials":633,"activeCount":82},[],{"trials":635,"activeCount":82},[],{"trials":637,"activeCount":82},[],{"trials":639,"activeCount":82},[],{"trials":641,"activeCount":82},[642],{"nctId":617,"briefTitle":618,"status":287,"phases":643,"primaryCompletion":620,"completion":621,"start":622,"enrollment":623,"conditions":644,"interventions":645},[74],[625,15],[604,627],{"trials":647,"activeCount":82},[],{"intervention":649,"totalTrials":78,"cells":650},"Desflurane",{"EARLY_PHASE1":651,"PHASE1":653,"PHASE2":655,"PHASE3":657,"PHASE4":659,"NA":672},{"trials":652,"activeCount":82},[],{"trials":654,"activeCount":82},[],{"trials":656,"activeCount":82},[],{"trials":658,"activeCount":82},[],{"trials":660,"activeCount":82},[661],{"nctId":662,"briefTitle":663,"status":287,"phases":664,"primaryCompletion":665,"completion":666,"start":667,"enrollment":668,"conditions":669,"interventions":670},"NCT04541823","The Effect of Desflurane on Postopertative Cognitive Dysfunction",[74],"2022-12","2023-03","2021-05-01",100,[306,32],[649,671],"Propofol",{"trials":673,"activeCount":82},[],{"intervention":675,"totalTrials":78,"cells":676},"Saxagliptin",{"EARLY_PHASE1":677,"PHASE1":679,"PHASE2":681,"PHASE3":683,"PHASE4":685,"NA":696},{"trials":678,"activeCount":82},[],{"trials":680,"activeCount":82},[],{"trials":682,"activeCount":82},[],{"trials":684,"activeCount":82},[],{"trials":686,"activeCount":82},[687],{"nctId":688,"briefTitle":689,"status":287,"phases":690,"primaryCompletion":691,"completion":692,"start":693,"enrollment":668,"conditions":694,"interventions":695},"NCT02583438","Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes",[74],"2017-10","2018-01","2015-10",[18,30],[675],{"trials":697,"activeCount":82},[],{"intervention":699,"totalTrials":78,"cells":700},"Byetta",{"EARLY_PHASE1":701,"PHASE1":703,"PHASE2":705,"PHASE3":707,"PHASE4":709,"NA":721},{"trials":702,"activeCount":82},[],{"trials":704,"activeCount":82},[],{"trials":706,"activeCount":82},[],{"trials":708,"activeCount":82},[],{"trials":710,"activeCount":82},[711],{"nctId":712,"briefTitle":713,"status":287,"phases":714,"primaryCompletion":715,"completion":692,"start":716,"enrollment":668,"conditions":717,"interventions":719},"NCT02584075","Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function",[74],"2017-11","2015-11",[718],"Coronary Endothelial Function",[699,720],"Glucophage",{"trials":722,"activeCount":82},[],{"intervention":720,"totalTrials":78,"cells":724},{"EARLY_PHASE1":725,"PHASE1":727,"PHASE2":729,"PHASE3":731,"PHASE4":733,"NA":739},{"trials":726,"activeCount":82},[],{"trials":728,"activeCount":82},[],{"trials":730,"activeCount":82},[],{"trials":732,"activeCount":82},[],{"trials":734,"activeCount":82},[735],{"nctId":712,"briefTitle":713,"status":287,"phases":736,"primaryCompletion":715,"completion":692,"start":716,"enrollment":668,"conditions":737,"interventions":738},[74],[718],[699,720],{"trials":740,"activeCount":82},[],{"intervention":742,"totalTrials":78,"cells":743},"CDD",{"EARLY_PHASE1":744,"PHASE1":746,"PHASE2":748,"PHASE3":750,"PHASE4":760,"NA":762},{"trials":745,"activeCount":82},[],{"trials":747,"activeCount":82},[],{"trials":749,"activeCount":82},[],{"trials":751,"activeCount":82},[752],{"nctId":753,"briefTitle":754,"status":287,"phases":755,"primaryCompletion":385,"completion":385,"start":386,"enrollment":668,"conditions":756,"interventions":758},"NCT02336386","CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma",[73],[757],"Extramedullary Plasmacytoma",[742,759],"CDD Plus Bortezomib",{"trials":761,"activeCount":82},[],{"trials":763,"activeCount":82},[],{"intervention":759,"totalTrials":78,"cells":765},{"EARLY_PHASE1":766,"PHASE1":768,"PHASE2":770,"PHASE3":772,"PHASE4":778,"NA":780},{"trials":767,"activeCount":82},[],{"trials":769,"activeCount":82},[],{"trials":771,"activeCount":82},[],{"trials":773,"activeCount":82},[774],{"nctId":753,"briefTitle":754,"status":287,"phases":775,"primaryCompletion":385,"completion":385,"start":386,"enrollment":668,"conditions":776,"interventions":777},[73],[757],[742,759],{"trials":779,"activeCount":82},[],{"trials":781,"activeCount":82},[],{"intervention":783,"totalTrials":78,"cells":784},"favipiravir tablets+chloroquine phosphatetablets",{"EARLY_PHASE1":785,"PHASE1":787,"PHASE2":789,"PHASE3":791,"PHASE4":805,"NA":807},{"trials":786,"activeCount":82},[],{"trials":788,"activeCount":82},[],{"trials":790,"activeCount":82},[],{"trials":792,"activeCount":82},[793],{"nctId":794,"briefTitle":795,"status":287,"phases":796,"primaryCompletion":797,"completion":798,"start":799,"enrollment":800,"conditions":801,"interventions":803},"NCT04319900","Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia",[72,73],"2020-04-30","2020-06-25","2020-03-05",150,[802],"Novel Coronavirus Pnuemonia",[783,804],"Favipiravir",{"trials":806,"activeCount":82},[],{"trials":808,"activeCount":82},[],{"intervention":804,"totalTrials":78,"cells":810},{"EARLY_PHASE1":811,"PHASE1":813,"PHASE2":815,"PHASE3":817,"PHASE4":823,"NA":825},{"trials":812,"activeCount":82},[],{"trials":814,"activeCount":82},[],{"trials":816,"activeCount":82},[],{"trials":818,"activeCount":82},[819],{"nctId":794,"briefTitle":795,"status":287,"phases":820,"primaryCompletion":797,"completion":798,"start":799,"enrollment":800,"conditions":821,"interventions":822},[72,73],[802],[783,804],{"trials":824,"activeCount":82},[],{"trials":826,"activeCount":82},[],{"intervention":828,"totalTrials":78,"cells":829},"ADV-TK (adenovirus-thymidine kinase enzyme) gene therapy",{"EARLY_PHASE1":830,"PHASE1":832,"PHASE2":834,"PHASE3":846,"PHASE4":848,"NA":850},{"trials":831,"activeCount":82},[],{"trials":833,"activeCount":82},[],{"trials":835,"activeCount":82},[836],{"nctId":837,"briefTitle":838,"status":348,"phases":839,"completion":840,"start":841,"enrollment":245,"conditions":842,"interventions":845},"NCT00300521","Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma",[72],"2005-11","2000-09",[843,844],"Hepatocellular Carcinoma","Liver Transplantation",[828],{"trials":847,"activeCount":82},[],{"trials":849,"activeCount":82},[],{"trials":851,"activeCount":82},[],{"intervention":853,"totalTrials":9,"cells":854},"Montelukast",{"EARLY_PHASE1":855,"PHASE1":857,"PHASE2":859,"PHASE3":870,"PHASE4":872,"NA":885},{"trials":856,"activeCount":82},[],{"trials":858,"activeCount":82},[],{"trials":860,"activeCount":82},[861],{"nctId":862,"briefTitle":863,"status":287,"phases":864,"primaryCompletion":865,"completion":693,"start":866,"enrollment":387,"conditions":867,"interventions":869},"NCT02352545","Montelukast for Postinfectious Cough",[72],"2015-08","2014-08",[868],"Cough",[853],{"trials":871,"activeCount":82},[],{"trials":873,"activeCount":82},[874],{"nctId":875,"briefTitle":876,"status":877,"phases":878,"primaryCompletion":879,"completion":880,"start":881,"enrollment":387,"conditions":882,"interventions":884},"NCT02655562","Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough","SUSPENDED",[74],"2024-12","2026-02","2016-04",[883],"Coughing",[853],{"trials":886,"activeCount":82},[887],{"nctId":888,"briefTitle":889,"status":287,"phases":890,"primaryCompletion":865,"completion":865,"start":866,"enrollment":387,"conditions":891,"interventions":892},"NCT02303600","Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough",[75],[883],[853],{"intervention":894,"totalTrials":272,"cells":895},"Remimazolam besylate",{"EARLY_PHASE1":896,"PHASE1":898,"PHASE2":900,"PHASE3":902,"PHASE4":904,"NA":906},{"trials":897,"activeCount":82},[],{"trials":899,"activeCount":82},[],{"trials":901,"activeCount":82},[],{"trials":903,"activeCount":82},[],{"trials":905,"activeCount":82},[],{"trials":907,"activeCount":82},[908,918],{"nctId":909,"briefTitle":910,"status":287,"phases":911,"primaryCompletion":912,"completion":912,"start":913,"enrollment":6,"conditions":914,"interventions":916},"NCT06332157","Postoperative Quality of Recovery After General Anesthesia With Remimazolam",[75],"2025-12","2024-09",[915],"Anesthesia Recovery Period",[894,917],"Propofol Injection Emulsion",{"nctId":919,"briefTitle":920,"status":287,"phases":921,"primaryCompletion":922,"completion":923,"start":924,"enrollment":529,"conditions":925,"interventions":929},"NCT06427785","The Effect of Wavelet Index in Monitoring the Sedation Depth of Remimazolam Besylate",[],"2024-08-17","2025-08-15","2024-08-15",[926,927,928],"Remimazolam","Anesthesia Awareness","Sedative, Hypnotic, or Anxiolytic Withdrawal",[894],{"intervention":415,"totalTrials":272,"cells":931},{"EARLY_PHASE1":932,"PHASE1":934,"PHASE2":936,"PHASE3":938,"PHASE4":940,"NA":946},{"trials":933,"activeCount":82},[],{"trials":935,"activeCount":82},[],{"trials":937,"activeCount":82},[],{"trials":939,"activeCount":82},[],{"trials":941,"activeCount":82},[942],{"nctId":407,"briefTitle":408,"status":348,"phases":943,"primaryCompletion":350,"completion":350,"start":351,"enrollment":410,"conditions":944,"interventions":945},[74],[15,26,412,413],[394,415],{"trials":947,"activeCount":82},[948],{"nctId":949,"briefTitle":950,"status":348,"phases":951,"primaryCompletion":484,"completion":484,"start":952,"enrollment":221,"conditions":953,"interventions":955},"NCT04925167","Safety and Efficacy of Argatroban Applicated in Anticoagulation of V-V ECMO",[75],"2021-07-06",[954],"Respiratory Failure",[956,957],"Argatroban","unfractionated heparin",{"intervention":671,"totalTrials":272,"cells":959},{"EARLY_PHASE1":960,"PHASE1":962,"PHASE2":964,"PHASE3":966,"PHASE4":968,"NA":974},{"trials":961,"activeCount":82},[],{"trials":963,"activeCount":82},[],{"trials":965,"activeCount":82},[],{"trials":967,"activeCount":82},[],{"trials":969,"activeCount":82},[970],{"nctId":662,"briefTitle":663,"status":287,"phases":971,"primaryCompletion":665,"completion":666,"start":667,"enrollment":668,"conditions":972,"interventions":973},[74],[306,32],[649,671],{"trials":975,"activeCount":82},[976],{"nctId":977,"briefTitle":978,"status":287,"phases":979,"primaryCompletion":980,"completion":981,"start":980,"enrollment":982,"conditions":983,"interventions":985},"NCT05519371","Remimazolam and Scoliosis Orthopedics",[75],"2022-10-01","2023-10-01",148,[984],"Benzodiazepines",[926,671],{"intervention":987,"totalTrials":78,"cells":988},"Selenium",{"EARLY_PHASE1":989,"PHASE1":991,"PHASE2":993,"PHASE3":995,"PHASE4":997,"NA":999},{"trials":990,"activeCount":82},[],{"trials":992,"activeCount":82},[],{"trials":994,"activeCount":82},[],{"trials":996,"activeCount":82},[],{"trials":998,"activeCount":82},[],{"trials":1000,"activeCount":82},[1001],{"nctId":1002,"briefTitle":1003,"status":287,"phases":1004,"primaryCompletion":1005,"completion":527,"start":1006,"enrollment":529,"conditions":1007,"interventions":1008},"NCT04942769","Study on the Effect of Selenium Supplementation on the Structure and Function of Autoimmune Thyroiditis",[75],"2021-07-30","2019-12-20",[987],[987],{"intervention":917,"totalTrials":78,"cells":1010},{"EARLY_PHASE1":1011,"PHASE1":1013,"PHASE2":1015,"PHASE3":1017,"PHASE4":1019,"NA":1021},{"trials":1012,"activeCount":82},[],{"trials":1014,"activeCount":82},[],{"trials":1016,"activeCount":82},[],{"trials":1018,"activeCount":82},[],{"trials":1020,"activeCount":82},[],{"trials":1022,"activeCount":82},[1023],{"nctId":909,"briefTitle":910,"status":287,"phases":1024,"primaryCompletion":912,"completion":912,"start":913,"enrollment":6,"conditions":1025,"interventions":1026},[75],[915],[894,917],{"intervention":1028,"totalTrials":78,"cells":1029},"Capecitabine",{"EARLY_PHASE1":1030,"PHASE1":1032,"PHASE2":1034,"PHASE3":1036,"PHASE4":1038,"NA":1040},{"trials":1031,"activeCount":82},[],{"trials":1033,"activeCount":82},[],{"trials":1035,"activeCount":82},[],{"trials":1037,"activeCount":82},[],{"trials":1039,"activeCount":82},[],{"trials":1041,"activeCount":82},[1042],{"nctId":1043,"briefTitle":1044,"status":287,"phases":1045,"primaryCompletion":1046,"enrollment":1047,"conditions":1048,"interventions":1050},"NCT02043821","Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker",[75],"2016-01",80,[1049],"Metastatic Colorectal Cancer",[1028],{"intervention":956,"totalTrials":78,"cells":1052},{"EARLY_PHASE1":1053,"PHASE1":1055,"PHASE2":1057,"PHASE3":1059,"PHASE4":1061,"NA":1063},{"trials":1054,"activeCount":82},[],{"trials":1056,"activeCount":82},[],{"trials":1058,"activeCount":82},[],{"trials":1060,"activeCount":82},[],{"trials":1062,"activeCount":82},[],{"trials":1064,"activeCount":82},[1065],{"nctId":949,"briefTitle":950,"status":348,"phases":1066,"primaryCompletion":484,"completion":484,"start":952,"enrollment":221,"conditions":1067,"interventions":1068},[75],[954],[956,957],{"intervention":1070,"totalTrials":78,"cells":1071},"Albuterol",{"EARLY_PHASE1":1072,"PHASE1":1074,"PHASE2":1076,"PHASE3":1078,"PHASE4":1080,"NA":1082},{"trials":1073,"activeCount":82},[],{"trials":1075,"activeCount":82},[],{"trials":1077,"activeCount":82},[],{"trials":1079,"activeCount":82},[],{"trials":1081,"activeCount":82},[],{"trials":1083,"activeCount":82},[1084],{"nctId":1085,"briefTitle":1086,"status":287,"phases":1087,"primaryCompletion":1088,"completion":1089,"start":1090,"enrollment":1091,"conditions":1092,"interventions":1094},"NCT02218398","Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients",[75],"2015-06","2015-12","2013-05",120,[1093],"Chronic Obstructive Pulmonary Disease",[1070],{"intervention":1096,"totalTrials":78,"cells":1097},"ERAS treatment",{"EARLY_PHASE1":1098,"PHASE1":1100,"PHASE2":1102,"PHASE3":1104,"PHASE4":1106,"NA":1108},{"trials":1099,"activeCount":82},[],{"trials":1101,"activeCount":82},[],{"trials":1103,"activeCount":82},[],{"trials":1105,"activeCount":82},[],{"trials":1107,"activeCount":82},[],{"trials":1109,"activeCount":82},[1110],{"nctId":1111,"briefTitle":1112,"status":287,"phases":1113,"primaryCompletion":289,"completion":290,"start":1114,"enrollment":245,"conditions":1115,"interventions":1118},"NCT04039646","ERAS in Patients With Perforated Peptic Ulcer Disease Who Underwent Laparoscopic Repair",[75],"2019-07-01",[1116,1117],"Hospital Stay","Hospital Cost",[1096],{"intervention":1120,"totalTrials":78,"cells":1121},"Only aspirin medication",{"EARLY_PHASE1":1122,"PHASE1":1124,"PHASE2":1126,"PHASE3":1128,"PHASE4":1130,"NA":1132},{"trials":1123,"activeCount":82},[],{"trials":1125,"activeCount":82},[],{"trials":1127,"activeCount":82},[],{"trials":1129,"activeCount":82},[],{"trials":1131,"activeCount":82},[],{"trials":1133,"activeCount":82},[1134],{"nctId":1135,"briefTitle":1136,"status":348,"phases":1137,"primaryCompletion":1138,"completion":1089,"start":1139,"enrollment":668,"conditions":1140,"interventions":1142},"NCT02802072","Enterprise Stent Implantation in the Treatment of Carotid Artery Stenosis With Ischemic Stroke",[75],"2014-01","2013-01",[1141],"Carotid Artery Stenosis",[1120],{"intervention":1144,"totalTrials":78,"cells":1145},"Bortezomib",{"EARLY_PHASE1":1146,"PHASE1":1148,"PHASE2":1150,"PHASE3":1152,"PHASE4":1154,"NA":1156},{"trials":1147,"activeCount":82},[],{"trials":1149,"activeCount":82},[],{"trials":1151,"activeCount":82},[],{"trials":1153,"activeCount":82},[],{"trials":1155,"activeCount":82},[],{"trials":1157,"activeCount":82},[1158],{"nctId":1159,"briefTitle":1160,"status":287,"phases":1161,"primaryCompletion":665,"completion":1162,"start":1163,"enrollment":1164,"conditions":1165,"interventions":1167},"NCT04678089","Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics",[],"2023-12","2019-05-16",350,[1166,1144],"Multiple Myeloma",[1144],{"intervention":926,"totalTrials":78,"cells":1169},{"EARLY_PHASE1":1170,"PHASE1":1172,"PHASE2":1174,"PHASE3":1176,"PHASE4":1178,"NA":1180},{"trials":1171,"activeCount":82},[],{"trials":1173,"activeCount":82},[],{"trials":1175,"activeCount":82},[],{"trials":1177,"activeCount":82},[],{"trials":1179,"activeCount":82},[],{"trials":1181,"activeCount":82},[1182],{"nctId":977,"briefTitle":978,"status":287,"phases":1183,"primaryCompletion":980,"completion":981,"start":980,"enrollment":982,"conditions":1184,"interventions":1185},[75],[984],[926,671],{"intervention":1187,"totalTrials":78,"cells":1188},"caspofungin",{"EARLY_PHASE1":1189,"PHASE1":1191,"PHASE2":1193,"PHASE3":1195,"PHASE4":1197,"NA":1199},{"trials":1190,"activeCount":82},[],{"trials":1192,"activeCount":82},[],{"trials":1194,"activeCount":82},[],{"trials":1196,"activeCount":82},[],{"trials":1198,"activeCount":82},[],{"trials":1200,"activeCount":82},[1201],{"nctId":1202,"briefTitle":1203,"status":287,"phases":1204,"primaryCompletion":1205,"start":716,"enrollment":160,"conditions":1206,"interventions":1208},"NCT02603575","Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV Patients",[75],"2020-12",[1207],"Pneumocystis Pneumonia",[1187,1209,1210],"corticosteroids","Sulfanilamides",{"intervention":1209,"totalTrials":78,"cells":1212},{"EARLY_PHASE1":1213,"PHASE1":1215,"PHASE2":1217,"PHASE3":1219,"PHASE4":1221,"NA":1223},{"trials":1214,"activeCount":82},[],{"trials":1216,"activeCount":82},[],{"trials":1218,"activeCount":82},[],{"trials":1220,"activeCount":82},[],{"trials":1222,"activeCount":82},[],{"trials":1224,"activeCount":82},[1225],{"nctId":1202,"briefTitle":1203,"status":287,"phases":1226,"primaryCompletion":1205,"start":716,"enrollment":160,"conditions":1227,"interventions":1228},[75],[1207],[1187,1209,1210],{"intervention":1210,"totalTrials":78,"cells":1230},{"EARLY_PHASE1":1231,"PHASE1":1233,"PHASE2":1235,"PHASE3":1237,"PHASE4":1239,"NA":1241},{"trials":1232,"activeCount":82},[],{"trials":1234,"activeCount":82},[],{"trials":1236,"activeCount":82},[],{"trials":1238,"activeCount":82},[],{"trials":1240,"activeCount":82},[],{"trials":1242,"activeCount":82},[1243],{"nctId":1202,"briefTitle":1203,"status":287,"phases":1244,"primaryCompletion":1205,"start":716,"enrollment":160,"conditions":1245,"interventions":1246},[75],[1207],[1187,1209,1210],{"intervention":1248,"totalTrials":78,"cells":1249},"Exenatide treatment",{"EARLY_PHASE1":1250,"PHASE1":1252,"PHASE2":1254,"PHASE3":1256,"PHASE4":1258,"NA":1260},{"trials":1251,"activeCount":82},[],{"trials":1253,"activeCount":82},[],{"trials":1255,"activeCount":82},[],{"trials":1257,"activeCount":82},[],{"trials":1259,"activeCount":82},[],{"trials":1261,"activeCount":82},[1262],{"nctId":1263,"briefTitle":1264,"status":348,"phases":1265,"primaryCompletion":1266,"completion":1267,"start":1268,"enrollment":1269,"conditions":1270,"interventions":1272},"NCT04303819","The Effect of Exenatide on Fasting Bile Acids",[],"2020-01-28","2020-01-31","2020-01-05",38,[1271],"Type 2 Diabetes Mellitus in Obese",[1248],{"intervention":1274,"totalTrials":78,"cells":1275},"duloxetine",{"EARLY_PHASE1":1276,"PHASE1":1278,"PHASE2":1280,"PHASE3":1282,"PHASE4":1284,"NA":1286},{"trials":1277,"activeCount":82},[],{"trials":1279,"activeCount":82},[],{"trials":1281,"activeCount":82},[],{"trials":1283,"activeCount":82},[],{"trials":1285,"activeCount":82},[],{"trials":1287,"activeCount":82},[1288],{"nctId":1289,"briefTitle":1290,"status":287,"phases":1291,"primaryCompletion":980,"completion":1292,"start":1293,"enrollment":245,"conditions":1294,"interventions":1296},"NCT04347577","Intestinal Flora and Major Depressive Disorders",[],"2023-04-01","2020-04-10",[1295],"Major Depressive Disorder",[1274],{"intervention":1298,"totalTrials":78,"cells":1299},"fresh frozen plasma",{"EARLY_PHASE1":1300,"PHASE1":1302,"PHASE2":1304,"PHASE3":1306,"PHASE4":1308,"NA":1310},{"trials":1301,"activeCount":82},[],{"trials":1303,"activeCount":82},[],{"trials":1305,"activeCount":82},[],{"trials":1307,"activeCount":82},[],{"trials":1309,"activeCount":82},[],{"trials":1311,"activeCount":82},[1312],{"nctId":1313,"briefTitle":1314,"status":287,"phases":1315,"primaryCompletion":1316,"completion":1316,"start":981,"enrollment":529,"conditions":1317,"interventions":1319},"NCT04107883","Effect of Transfusion of Plasma on Endothelial During Liver Transplantation",[75],"2024-12-31",[1318,844],"End Stage Liver DIsease",[1298],{"intervention":1321,"totalTrials":78,"cells":1322},"self-expanding metallic stent placement followed by neoadjuvant chemotherapy",{"EARLY_PHASE1":1323,"PHASE1":1325,"PHASE2":1327,"PHASE3":1329,"PHASE4":1331,"NA":1333},{"trials":1324,"activeCount":82},[],{"trials":1326,"activeCount":82},[],{"trials":1328,"activeCount":82},[],{"trials":1330,"activeCount":82},[],{"trials":1332,"activeCount":82},[],{"trials":1334,"activeCount":82},[1335],{"nctId":1336,"briefTitle":1337,"status":348,"phases":1338,"primaryCompletion":1339,"completion":1339,"start":1340,"enrollment":1341,"conditions":1342,"interventions":1344},"NCT04039360","SEMS Placement Followed by Chemotherapy and Surgery for Obstructing Left-sided Colonic Cancer",[],"2015-11-30","2014-05-01",11,[1343],"Complication of Treatment",[1321],{"intervention":1346,"totalTrials":78,"cells":1347},"Methylprednisolone",{"EARLY_PHASE1":1348,"PHASE1":1350,"PHASE2":1352,"PHASE3":1354,"PHASE4":1356,"NA":1358},{"trials":1349,"activeCount":82},[],{"trials":1351,"activeCount":82},[],{"trials":1353,"activeCount":82},[],{"trials":1355,"activeCount":82},[],{"trials":1357,"activeCount":82},[],{"trials":1359,"activeCount":82},[1360],{"nctId":1361,"briefTitle":1362,"status":348,"phases":1363,"primaryCompletion":1364,"completion":1364,"start":1365,"enrollment":1366,"conditions":1367,"interventions":1370},"NCT04273321","Efficacy and Safety of Corticosteroids in COVID-19",[75],"2020-04-15","2020-02-14",86,[1368,1369],"COVID-19","Novel Coronavirus Pneumonia",[1346],{"intervention":1372,"totalTrials":78,"cells":1373},"Daratumumab + Bortezomib + Dexamethasone + Dapagliflozin",{"EARLY_PHASE1":1374,"PHASE1":1376,"PHASE2":1378,"PHASE3":1380,"PHASE4":1382,"NA":1384},{"trials":1375,"activeCount":82},[],{"trials":1377,"activeCount":82},[],{"trials":1379,"activeCount":82},[],{"trials":1381,"activeCount":82},[],{"trials":1383,"activeCount":82},[],{"trials":1385,"activeCount":82},[1386],{"nctId":1387,"briefTitle":1388,"status":287,"phases":1389,"primaryCompletion":1390,"completion":1391,"start":1392,"enrollment":245,"conditions":1393,"interventions":1395},"NCT06297681","Combination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Disease",[],"2025-01-30","2025-12-31","2024-03-15",[1394],"M-protein Related Cardiac Disease",[1372],{"intervention":1397,"totalTrials":78,"cells":1398},"paxlovid",{"EARLY_PHASE1":1399,"PHASE1":1401,"PHASE2":1403,"PHASE3":1405,"PHASE4":1407,"NA":1409},{"trials":1400,"activeCount":82},[],{"trials":1402,"activeCount":82},[],{"trials":1404,"activeCount":82},[],{"trials":1406,"activeCount":82},[],{"trials":1408,"activeCount":82},[],{"trials":1410,"activeCount":82},[1411],{"nctId":1412,"briefTitle":1413,"status":287,"phases":1414,"primaryCompletion":302,"completion":37,"start":1415,"enrollment":1416,"conditions":1417,"interventions":1418},"NCT05792865","A Registry Study of Patients Hospitalized With Confirmed COVID-19",[],"2023-03-30",488,[1368],[1397,1419,1420],"No paxlovid","Paxlovid",{"intervention":1419,"totalTrials":78,"cells":1422},{"EARLY_PHASE1":1423,"PHASE1":1425,"PHASE2":1427,"PHASE3":1429,"PHASE4":1431,"NA":1433},{"trials":1424,"activeCount":82},[],{"trials":1426,"activeCount":82},[],{"trials":1428,"activeCount":82},[],{"trials":1430,"activeCount":82},[],{"trials":1432,"activeCount":82},[],{"trials":1434,"activeCount":82},[1435],{"nctId":1412,"briefTitle":1413,"status":287,"phases":1436,"primaryCompletion":302,"completion":37,"start":1415,"enrollment":1416,"conditions":1437,"interventions":1438},[],[1368],[1397,1419,1420],{"intervention":1440,"totalTrials":78,"cells":1441},"Ischemic Stroke",{"EARLY_PHASE1":1442,"PHASE1":1444,"PHASE2":1446,"PHASE3":1448,"PHASE4":1450,"NA":1452},{"trials":1443,"activeCount":82},[],{"trials":1445,"activeCount":82},[],{"trials":1447,"activeCount":82},[],{"trials":1449,"activeCount":82},[],{"trials":1451,"activeCount":82},[],{"trials":1453,"activeCount":82},[1454],{"nctId":1455,"briefTitle":1456,"status":287,"phases":1457,"primaryCompletion":1458,"completion":1459,"start":881,"enrollment":387,"conditions":1460,"interventions":1461},"NCT02756494","Ischemic Stroke in Chinese Young Adults",[],"2018-04","2018-12",[1440],[1440]]